ARVO Disclosure Guidelines

Slides:



Advertisements
Similar presentations
VCOM Conflict of Interest Policy Overview of Financial Conflict of Interest Related to Research December 4, 2013.
Advertisements

Financial Conflict of Interest July 2012 rev
Managing Conflicts of Interest © ACCME.
Reviewer Disclosure Guide 1) Ensure disclosed information is complete Reviewer Responsibilities 2) Assign a conflict of interest category 3) Develop management.
Japan Society for Hematopoietic Cell Transplantation COI disclosure Name of first author : e.g., John Doe I have no personal or financial interests to.
Disclose to APM and meeting attendees the existence of any financial relationships with any for-profit companies that are directly or indirectly related.
[Session Number: Title] [Speaker Optional: Job title Institution]
ARVO Disclosure Guidelines Presenting Authors must fully disclose to ARVO and the session participants all commercial relationships relevant to the subject.
Title text here in Arial or Helvetica Bold 40 Adjust font size as needed. Presentation (Program) Number (Number provided in the body of your Abstract Scheduling.
Financial Interest Disclosure (over the past 24 months) Commercial Interest Relationship Company A advisory board, consultant, investigator Company B speaker.
YOUR DISCLOSURE STATEMENT
Insert Abstract Title Text Here in Calibri, Arial, or Helvetica
, when no conflicts of interest to disclose exist
We have no conflict of interests related to
Conflict of Interest Disclosure
Conflict of Interest Disclosure
様式1AB (Form 4-C) Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.
CCT2017 COI Disclosure Name of First Author : XXXXXXXXXXXXXX
2018 Canadian Transplant Summit - DISCLOSURE FORM
DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.
The Japanese Circulation Society COI Disclosure Name of Authors :
Relevant Financial Disclosure(s)
Japanese Society of Allergology COI Disclosure Name of lead presenter
The Japanese Circulation Society COI Disclosure Name of Authors :
Conflict of Interest Disclosure:
Copyright © 2016 by ASCP.
Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.
TOPIC 2018 COI Disclosure Name of Author :
Conflict of Interest Disclosure (over the past 24 months)
Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.
Disclosure of conflicts of interest – explanation
Conflict of Interest Disclosure
COI Disclosure All authors Name : (◎ Corresponding author)
DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.
DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.
DISCLOSURE INFORMATION
DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.
Disclosures The project was funded from the following sources:
Financial Disclosure Financial Interest / Affiliation
Disclosures Relevant financial relationships in the past twelve months by presenter or spouse/partner.    Employment: Company Name(s) Speakers Bureau:
Conflict of Interest Disclosure
Title of Talk Speaker name.
DISCLOSURE INFORMATION
, when no conflicts of interest to disclose exist
Use the following slide to disclose any conflicts of interest
DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.
Disclosure Guidelines
Disclosure Guidelines
Disclosure of conflicts of interest
様式1AB (Form 4-C) Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.
We have no conflict of interests related to
Please use the sample slide format to disclose COI status.
様式1AB (Form 4-C) Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.
Presentation (Program) Number
COI Disclosure Name of Author: Gildong Hong
Disclosure of conflicts of interest
We have no conflict of interests related to
Please use the sample slide format to disclose COI status.
様式1AB (Form 4-C) Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.
COI Disclosure All authors Name : (◎ Corresponding author)
Financial and Other Disclosures
Financial Disclosure Financial Interest / Affiliation
CCT2018 COI Disclosure Name of First Author : XXXXXXXXXXXXXX
 *Please use this slide template when there is no
Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.
Please include this slide if you answered “yes” to at least one of the questions.
様式1AB (Form 4-C) Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.
Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.
様式1AB (Form 4-C) Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.
COI Disclosure For speakers with a COI to declare
Presentation transcript:

ARVO Disclosure Guidelines Presenting Authors must fully disclose to ARVO and the session participants all commercial relationships relevant to the subject matter for all authors of the presentation and their spouse or partner for the prior 24 months. All full disclosures must be indicated orally and on a slide at the beginning of the presentation. A full disclosure will include the name(s) of the commercial interest and the nature of the relationship(s). Indicate “None” if no relationships exist. View the ARVO Commercial Relationships Policy for complete reporting requirements.

ARVO Disclosure Codes Definitions F (Financial Support) Indicates financial support received from an ACCME-defined commercial interest, in the form of research funding, grants, research materials or in-kind services (e.g., protein sequencing). I (Personal Financial Interest) Indicates you are an investor in a company or competing company, including an ACCME-defined commercial interest, other than through a mutual or retirement fund. E (Employment) Indicates you are an employee of an ACCME-defined commercial interest. C (Consultant) Indicates you are a consultant for an ACCME-defined commercial interest. P (Patent) Indicates you are an inventor/developer designated on a patent, patent application, copyright, or trade secret, whether or not the patent, copyright, etc. is presently licensed or otherwise commercialized, or could be in competition with the technology described. R (Recipient) Indicates you have received gifts, honoraria, travel reimbursement, patent royalties, or any other financial compensation valued in any amount from an ACCME-defined commercial interest. N (No Commercial Relationship) Indicates there is no commercial relationship relevant to the subject matter of the abstract/article/presentation. S (non-remunerative) Indicates you have position(s) of influence such as officer, board member, trustee, spokesperson, etc.

Disclosure Example 1 F (Financial Support): Acme Company (research funding) I (Personal Financial Interest): Cyberdyne Systems Corp. (shareholder) C (Consultant): Stark Industries, Tyrell Corp, Wayne Enterprises (consultant) P (Patent): Cyberdyne Systems Corp. (licensed patents related to cybernetic prostheses) R (Recipient): Cyberdyne Systems Corp. (dividends and royalties) S: Globex, Oscorp, Virtucon (non-remunerated board member)

Disclosure Example 2 Acme Company (F), Cyberdyne Systems Corp. (I, P, R),  Globex (S), Oscorp (S), Stark Industries (C), Tyrell Corp (C), Virtucon (S), Wayne Enterprises (C)

Disclosure Example 3 N: No commercial relationships relevant to the subject matter of the presentation

Disclosure Example 4 Commercial Relationships: None